Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2017-05-17 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2017-05-17 Chen Henry Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Chen Henry Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2017-03-29 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-03-20 ROYSTON IVOR Director Returned to the company −125,000 $13.75 $1.7M 625,545
2017-02-13 Shea Richard P Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2017-02-06 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000
2017-02-06 Morrison Briggs Chief Executive Officer Grant or award · Stock Option (Right to Buy) +160,000 160,000
2017-02-06 Meyers Michael L. SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +66,100 66,100
2017-02-06 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +95,000 95,000
2017-01-04 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-10-31 Chen Henry Director Grant or award · Stock Options (Right to buy) +8,000 8,000
2016-10-31 Sledge George W. Jr. Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 Shea Richard P Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 ROYSTON IVOR Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 EVNIN LUKE Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2016-10-31 Kamdar Kim P. Director Grant or award · Stock Option (Right to Buy) +8,000 8,000

Page 26 of 28 · 550 trades